SATIRN Trademark

Trademark Overview

On Tuesday, September 13, 2016, a trademark application was filed for SATIRN with the United States Patent and Trademark Office. The USPTO has given the SATIRN trademark a serial number of 87169241. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Wednesday, July 17, 2024. This trademark is owned by Batavia Biosciences BV. The SATIRN trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Research and development of vaccines and medicines
satirn

General Information

Serial Number87169241
Word MarkSATIRN
Filing DateTuesday, September 13, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateWednesday, July 17, 2024
Registration Number5439047
Registration DateTuesday, April 3, 2018
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, January 31, 2017

Trademark Statements

Description of MarkThe mark consists of the word "SATIRN" in black to the right of a disk made up of green spheres circumferentially bound by two orange bands.
Indication of Colors claimedThe color(s) green, orange, and black is/are claimed as a feature of the mark.
Goods and ServicesResearch and development of vaccines and medicines

Classification Information

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, September 16, 2016
Primary Code042
First Use Anywhere DateWednesday, November 8, 2017
First Use In Commerce DateWednesday, November 8, 2017

Trademark Owner History

Party NameBatavia Biosciences BV
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLeiden NL-2333CL
NL
Party NameBatavia Biosciences BV
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLeiden NL-2333CL
NL
Party NameBatavia Biosciences BV
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLeiden NL-2333CL
NL

Trademark Events

Event DateEvent Description
Monday, December 19, 2016ASSIGNED TO EXAMINER
Monday, December 19, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, September 16, 2016NEW APPLICATION ENTERED
Friday, September 16, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, September 17, 2016NOTICE OF DESIGN SEARCH CODE E-MAILED
Tuesday, January 23, 2018TEAS STATEMENT OF USE RECEIVED
Wednesday, January 11, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 31, 2017PUBLISHED FOR OPPOSITION
Tuesday, January 31, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 28, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Sunday, August 6, 2017SOU TEAS EXTENSION RECEIVED
Sunday, August 6, 2017SOU EXTENSION 1 FILED
Sunday, August 6, 2017SOU EXTENSION 1 GRANTED
Tuesday, August 8, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, February 5, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, February 13, 2018STATEMENT OF USE PROCESSING COMPLETE
Monday, February 26, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, February 27, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Thursday, July 19, 2018ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, April 3, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, January 23, 2018USE AMENDMENT FILED
Tuesday, April 3, 2018REGISTERED-PRINCIPAL REGISTER
Thursday, July 19, 2018TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 7, 2018CORRECTION UNDER SECTION 7 - PROCESSED
Thursday, January 4, 2024TEAS SECTION 8 & 15 RECEIVED
Wednesday, July 17, 2024CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, July 17, 2024REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Wednesday, July 17, 2024NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED

Related Keywords

satirn medicines vaccines development research